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Abstract: Early programming is the adaptation process by which nutrition and environmental factors
alter development pathways during prenatal growth, inducing changes in postnatal metabolism
and diseases. The aim of this narrative review, is evaluating the current knowledge in the scientific
literature on the effects of nutrition, environmental factors, physical activity and sleep on development
pathways. If in utero adaptations were incorrect, this would cause a mismatch between prenatal
programming and adulthood. Adequate caloric intake, protein, mineral, vitamin, and long-chain
fatty acids, have been noted for their relevance in the offspring brain functions and behavior.
Fetus undernutrition/malnutrition causes a delay in growth and have detrimental effects on the
development and subsequent functioning of the organs. Pregnancy is a particularly vulnerable
period for the development of food preferences and for modifications in the emotional response.
Maternal obesity increases the risk of developing perinatal complications and delivery by cesarean
section and has long-term implications in the development of metabolic diseases. Physical exercise
during pregnancy contributes to overall improved health post-partum. It is also interesting to
highlight the relevance of sleep problems during pregnancy, which influence adequate growth and
fetal development. Taking into account these considerations, we conclude that nutrition and metabolic
factors during early life play a key role of health promotion and public health nutrition programs
worldwide to improve the health of the offspring and the health costs of hospitalization.
Keywords: nutritional programming; eclampsia; birth weight; cardiovascular disease; metabolic
programming; physical activity; sleep; obesity; pregnancy
1. Introduction
Early programming is defined as the adaptation process by which nutrition and other
environmental factors alter in utero fetal development, thereby inducing changes in metabolism
and the susceptibility to chronic disease in adulthood [1]. Animal studies showed that the fetus can
adapt to malnutrition, altering its hormonal production or the sensitivity of tissues to hormones and
insulin has a key role regulating fetal growth, and therefore the need for nutrients [2]. The fetus can
alter its metabolism, for example, by changing the oxidation of glucose to that of amino acids, can also
redistribute blood flow to major organs like the brain and can even adapt to slower growth to decrease
substrate demands. However, contrary to the physiological adaptations that occur in the adult, those of
the fetus lead to permanent changes in body structure and function [3].
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Early programming begins before conception, because during production of both male and female
primordial germ cells, most epigenetic imprints (such as DNA methylation, histone modification,
and microRNAs) included in the parent’s DNA are eliminated, although in some cases these imprints
remain [4,5]. On the other hand, the development period from preconception to early childhood
is the time when epigenetic imprinting of DNA occurs most actively, which leads to alterations in
gene expression with lasting effects [6]. Nutrition is, from all the environmental factors, one of the
most important quantitatively in the environment-gene relationship, therefore prenatal and postnatal
nutrition are the most influential environmental factors during fetal and infant development [7].
In addition, the fetal period has enormous plasticity and capacity to respond to the lifestyle and
the maternal environment [8], and nutrition plays a fundamental role in this stage since it induces
permanent methylation of DNA [9].
The dietary components (vitamins, micronutrients, amino acids, fats or carbohydrates) can affect
the function and expression of genes in the uterus and during the early stages of life by modulating
epigenetic mechanisms mediated by the metabolism of folates in the metabolism of carbohydrates or in
the transmethylation processes that affect the methylation of DNA, histones or non-coding miRNAs [8].
This is an area of epigenetic research, in which it is studied whether epigenetic alterations induced
by the maternal diet program the offspring to be more susceptible to certain pathologies such as
cardiovascular diseases, obesity, diabetes [5].
The link between the intrauterine environment and the risk of disease in adulthood was first
studied in the 1980s, showing that there was a higher mortality from cardiovascular diseases in
newborns with low birth weight, data confirmed later by studies that also found an association between
low birth weight with an increased risk of obesity, diabetes mellitus type II and hypertension [10–12].
Based on these findings, Barker proposed the “thrifty phenotype” hypothesis, also known as the
“Barker hypothesis” [13], reporting that exposure to inadequate nutrition during pregnancy and
childhood predisposes offspring to developing diabetes mellitus type II. This theory proposes that
malnutrition, regardless of the cause, limits the fetus growth by prioritizing blood flow to the
brain, thus decreasing the flow to muscle, liver, pancreas and kidneys. In addition, secretion and
sensitivity to hormones that promote fetal growth such as insulin or insulin-like factors are reduced [14].
The further development of this hypothesis gave rise to the theory of the origin of health and disease
(The Developmental Origins of Health and Disease, DOHaD) [5,12,14], which established that the fetus
has capacity to make adaptations based on signals from the in utero environment, thus allowing to
improve the immediate survival under adverse postnatal environment. If in utero adaptations are
incorrect or significant changes occur in the environment after birth, this would cause a mismatch
between prenatal programming and postnatal life and, therefore, induce an increased risk of disease in
adulthood [15] (Figure 1).
The first studies that clearly showed the relationship between nutrition during pregnancy and
the risk of disease in adulthood were those developed during the 1944 Dutch famine [11]. In these
studies, it was observed that the children of women exposed to famine periconceptionally or during
the first trimester of gestation presented newborns with similar weights to the children of mothers
not exposed to it, however, in adulthood they featured increased risk of cardiovascular disease and
diabetes. In those cases, in which exposure to famine took place in more advanced stages of gestation,
the birth weight was lower among the children of women exposed to famine, also presenting a higher
incidence of hypertension and insulin resistance in the adulthood [11].
There is increasing evidence in the scientific literature showing that embryonic or fetal exposure
to nutrients can affect their epigenetics and many of these changes are lasting throughout lifespan [16],
and can be the most plausible etiology of pathologies such as some types of cancer, cardiovascular disease
or metabolic diseases [17]. However, not only malnutrition affects the epigenome, overnutrition also
involves metabolic programming and an increased risk of cardiovascular disease, obesity, hypertension,
atherosclerosis and diabetes mellitus [9].
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Figure 1. Influence of several factors on offspring development. 
On the other hand, physiological changes that occur during pregnancy, are associated with 
changes in sleep architecture. These changes can cause negative effects on the health of the mother 
and her offspring both at a psychological level, as well as at a metabolic and epigenetic level [21]. 
Also, sleep duration and quality have an impact in dietary patterns which has a direct impact on the 
offspring’s health outcomes [22]. 
Taking into account all the mentioned above, the aim of this narrative review, is evaluating the 
current knowledge in the scientific literature on the effects of nutrition, environmental factors, 
physical activity and sleep on development pathways during prenatal growth, and their effects in 
lifelong metabolism and diseases. 
2. Materials and Methods 
The search dated from 3 January 2020 to 2 September 2020. Website search engines and 
electronic databases such as PubMed, Scielo and Cochrane were used, including consistent key 
words such as early programming, metabolic programming, in utero programming, maternal diet, 
fetal growth. Dates of all publications were noted if available. The inclusion criteria were: 
manuscripts with expertise in the field of nutrition. Exclusion criteria were: manuscripts written in a 
i . I fl f l f t ff ri l t.
Nutrition and physical activity during pregnancy are correlated, showing that maternal
malnutrition can lead to a sedentary life in the offspring [18]. This aspect is of great importance,
since physical activity during pregnancy has been positively related to various healthy aspects both in
the mother and in the newborn [19]. Recently, growing evidence in the scientific literature, indicates that
physical activity is necessary to prevent possible metabolic disturbances in the offspring and also
may have a positive correlation with offspring’s neurodevelopment and language (in children from
18 to 60 months) [20].
On the other hand, physiological changes that occur during pregnancy, are associated with
changes in sleep architecture. These changes can cause negative effects on the health of the mother
and her offspring both at a psychological level, as well as at a metabolic and epigenetic level [21].
Also, sleep duration and quality have an impact in dietary patterns which has a direct impact on the
offspring’s health outcomes [22].
Taking into account all the mentioned above, the aim of this narrative review, is evaluating
the current knowledge in the scientific literature on the effects of nutrition, environmental factors,
physical activity and sleep on development pathways during prenatal growth, and their effects in
lifelong metabolism and diseases.
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2. Materials and Methods
The search dated from 3 January 2020 to 2 September 2020. Website search engines and electronic
databases such as PubMed, Scielo and Cochrane were used, including consistent key words such
as early programming, metabolic programming, in utero programming, maternal diet, fetal growth.
Dates of all publications were noted if available. The inclusion criteria were: manuscripts with expertise
in the field of nutrition. Exclusion criteria were: manuscripts written in a language different from
English or Spanish, webinars, blogs or podcasts. Keywords included were: “Nutritional programming”;
“Birth weight”; “Metabolic programming”; “Physical activity”; “Sleep”; “Pregnancy”. After screening of
titles and abstracts, 49 manuscripts were selected for further examination. Subsequently 2 manuscripts
were excluded due to lack of relevance, therefore 47 papers were included in this narrative review.
Text from each manuscript was extracted into an excel document and reviewed to find repeated issues
by the authors. The topics, main objectives and key words were agreed by all authors.
3. Maternal Diet and the Influence in Offspring Health
3.1. Influence of Maternal Diet on Cognitive Development and Behavior
There are several critical periods for brain development which include the third trimester of
gestation to two years of the child’s life. These periods are characterized by great maturation and
brain growth [23]. There are other critical periods that also been highlighted as early organizational
processes which occur during the first trimester of gestation, they are highly relevant and include
cell migration, differentiation, neurogenesis, synaptogenesis, and maturation of neurotransmission
pathways [24]. Adequate caloric intake, protein (which avoids embryonic losses, intra-uterine
growth restriction, and reduced postnatal growth), and some minerals such as, iron (critical for
rapid development and proliferation playing a key role in brain development), zinc (which affects
fetal growth), selenium (which avoids risk of infant infection and improves psychomotor score),
copper (necessary for rapid growth and cell differentiation for both the mother and fetus) and iodine
(which favors thyroid and neurological development), have been noted for their special relevance in
these processes. In this sense, some vitamins and other nutrients, such as folate (which helps form the
neural tube and cell proliferation), vitamin A (which aids in both cell development and brain growth),
choline (which influences stem cell proliferation and brain and spinal cord structure and function) and
long-chain fatty acids (which play important roles as precursors of prostaglandins and as structural
elements of cell membranes), also play an essential role in these processes [23]. Hence, an inadequate
diet, which does not provide these main nutrients in the right amount during this critical period,
can alter irreversibly the offspring brain functions and behavior. In this sense, Coo et al. [25] reported
modest associations between maternal obesity and offspring performance intelligence quotient, with a
weak biologic effect of maternal adiposity in pregnancy on offspring performance intelligence quotient.
With regard to the intake behavior, some studies have shown how exposure to a high-fat diet or
cafeteria-style diet at critical moments in development can cause hyperphagia [26–28]. The increase
in appetite in the offspring has also been evidenced after exposure to caloric restriction in animal
models [29–31]. In the lifelong, regarding the preference for meals, different investigations point to the
existence of critical periods for their programming. Thus, studies conducted in humans exposed to
famines in the perinatal period or with restricted intrauterine growth have shown, in later stages, a high
preference for food rich in fats [32] or rich in sugars [33]. In relation to critical periods, some research
considers pregnancy to be a particularly vulnerable period for the development of food preferences,
as a high correlation was found between maternal energy and macronutrient intake in pregnancy,
with the intake of children at 10 years old [34]. Other studies also point to the early postnatal period,
showing a positive relationship between the type of food to which children have been exposed during
pregnancy and lactation, with their preferences in the weaning period [35], and also showing how
exposure to certain flavors during lactation increases the preference for specific foods in the childhood
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such as broccoli in those fed hydrolysate or soy formulas, meanwhile this food was not preferred by
those who were fed milk formulas [36].
Apart from the alterations in the intake behavior, modifications in the emotional response
have been documented in animal models after exposure to a hypercaloric maternal diet [37–39],
a protein restriction diet [40,41] or a hypocaloric diet [42,43]. In general, it has been shown that
perinatal exposure to a high fat diet increases anxiety-related behaviors, this effect being similar
regardless of whether the animals have been exposed during fetal or early postnatal life [37,39,44].
In contrast, in some studies carried out in animal models of caloric restriction, exposure during early
pregnancy and/or during lactation has been shown to increase anxiety-related behaviors compared
to other stages of pregnancy [42,43]. In the case of protein restriction, it has been found, in general,
that animals exposed to it during gestation exhibit a greater number of exploratory behaviors or great
impulsivity [45], but the opposite effect has also been found when protein malnutrition includes both
lactation and gestation [41]. Furthermore, in these models, modifications in behaviors related to depression
have been described, including problems related to learning, memory, neuromuscular coordination,
and behavioral development, although the underlying mechanisms affected are unknown [41].
As regards human studies, in children with low birth weight, a high risk in suffering from
anxiety disorders and/or mood disorders has also been reported [46]. Furthermore, a high correlation
has been found between the preconception body mass index and maternal obesity with inattention
symptoms and negative emotionality in children [47], establishing a link between obesity and emotional
difficulties, as fetal brain development depends on maternal substrates supply. Studies of changes in
maternal diet and epigenetic gene regulation have focused primarily on the hypothalamus, relating the
increased risks of obesity faced by offspring of poor-quality maternal diets. There are a high number
of alterations in hypothalamic subregions by gestational diets, including epigenetic mechanisms.
Excessive feeding in rodents, severely reduced litter size, led to methylation of the proopiomelanocortin
(POMC) gene in the hypothalamus, and induced dysfunctions in homeostatic feeding mechanisms
and energy balance [48]. In human environments there is an equally important role for hedonic and
motivational feeding, which is supported by brain regions that are important for reward function.
In this case, the underlying mechanisms can be explained because overweight in pregnancy increases
concentrations of insulin, interleukin-6, and leptin and placental transfer of glucose which increases the
risk for neurobehavioral impairments, inducing disturbed maternal metabolic function, which could
also support the hypothesis that maternal metabolic status increases the risk of develop behavioral
disturbances in children [47,49].
3.2. Role of Malnutrition in Development and Lifelong Consequences
Intrauterine growth retardation occurs more frequently in the context of placental insufficiency [50],
generally related to preeclampsia or hypertension [51], although it can also occur as a result of unhealthy
maternal diet [51,52]. Fetus undernutrition or malnutrition causes intrauterine growth retardation,
inducing low birth weight. Regardless of the causative events, poor intrauterine nutrients supply
activates a process in which the fetus responds through physiological adaptations, which involve
optimizing the bioavailability of nutrients and diverting blood supply to the brain and other key organs.
These adaptations increase the survival rate, but result in a delay in growth and have detrimental effects
on the development and subsequent functioning of the organs, which affect the renal, cardiovascular,
respiratory, and endocrine systems [51,53,54]. Bacchetta et al. [53] examined the impact of intrauterine
growth retardation on renal function in preterm infants, finding that infants with intrauterine growth
retardation had the least developed renal system, with fewer nephrons than infants with normal
intrauterine growth. These authors also found that children affected by intrauterine growth retardation
had higher glomerular filtration rates, which means that the nephrons were working more forcibly.
These two factors predispose children with intrauterine growth retardation to future kidney failure.
Similar effects affect the development and function of other organs. For example, several authors have
studied the affectation in the development of pancreatic beta cells in response to fetal programming
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during intrauterine growth retardation [50]. This situation leads to a reduction in the insulin secretion
and a predisposition to glucose intolerance in the adulthood [50]. Fetal malnutrition also predisposes
to cardiac pathologies [54] and lung disease [51]. Therefore, the effects of fetal programming help the
fetus survive in adverse conditions, leading to mechanisms of nutritional saving and the ability to
survive with restricted nutrition, although with adverse consequences latter in life [13]. When nutrition
is no longer restricted, in the postnatal period, the homeostasis of energy balance is profoundly altered
predisposes the offspring to suffer insulin resistance, obesity and chronic diseases such as diabetes and
hypertension [13].
In relation to micronutrients, there is consensus on the scientific literature about the benefit of
iodine, iron and folic acid supplements before and during pregnancy. This supplementation must be
provided by a healthcare professional, since self-medication with these preparations can cause health
problems in the pregnant woman and the fetus [55–57]. Vitamin B12 and especially folic acid deficiency
are the most important causes of nutritional anemia. The manifestations of its deficiencies are due to
the decrease in nucleic acid synthesis, altering nuclear maturation and preferentially affecting cells
with rapid proliferation. The most common signs and symptoms are megaloblastic anemia, risk of
premature delivery, low birth weight, neural tube closure defects, and spina bifida [58,59].
Iron is necessary to prevent anemia which is associated with an increased risk of negative
consequences during pregnancy: low birth weight and premature delivery [60]. It is also important for
the development of the fetus and the placenta. Iron preparations should be ingested under fasting
conditions and their absorption is improved in presence of vitamin C. Iodine is essential for the
synthesis of thyroid hormone, essential for the development of all organs, especially the central nervous
system, so that a Iodine deficiency has detrimental effects on the fetus. WHO advises a daily intake of
250 µg for pregnant women and during lactation (Leung et al., 2011). Micronutrient supplementation
before and during pregnancy is associated with an increase in birth weight, a decrease in risk of preterm
birth, gestational hypertension and preeclampsia and even improvement of the mental development
of the offspring [61].
3.3. Metabolic Syndrome and Nutritional Programming
The relationship between episodes of early nutritional restriction and the subsequent appearance
of pathologies associated with the metabolic syndrome, such as obesity and type II diabetes, has been
revealed through different epidemiological studies in humans [62–64] and experimental studies carried
out on laboratory animals [65,66]. It has been suggested that the gene pool acquired during evolution
would have sensitized certain individuals to develop more markedly, different metabolic pathologies
associated with overfeeding and sedentary lifestyle habits, is what is known as the hypothesis of the
“thrifty genotype” [67]. Subsequently, and in a complementary way, the thrifty phenotype hypothesis
was reported by Hales and Barker [13,68], and according to this, a deficient nutritional contribution
during development would propitiate the programming of certain genes and metabolic processes,
with the aim of accommodating the organism to a limited supply of nutrients, conferring a survival
advantage [69]. However, these adaptations would increase vulnerability to subsequent obesogenic
or diabetogenic stimuli [70,71]. This hypothesis was formulated after finding, through numerous
epidemiological studies [62,72,73], that different communities subjected to nutritional restriction
during critical stages of development were more likely to suffer pathologies associated with metabolic
syndrome during adulthood.
The fact that not all subjects develop accelerated growth after an episode of early nutritional
restriction, and that it differs in terms of the severity of its consequences in adulthood, raises the
possibility that both hypotheses, thrifty genotype and phenotype, share essential aspects when
explaining the metabolic programming process. In any case, it seems evident, from the numerous
studies carried out to date, that the nutritional environment during the perinatal period represents a
key stage in the development of pathologies in adults. Also, in recent years, a branch of computational
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biology, epigenetics, tries to shed light on the causes that would cause the activation or deactivation of
certain genes involved in the subsequent development of these pathologies [74].
The hypothesis that nutritional restriction during perinatal growth is associated with the appearance
of metabolic diseases in adulthood has been investigated in different animal models [65,75,76]. In these
models, intrauterine growth restriction leads to abnormalities in the endocrine function of multiple
glands and hormonal systems of term fetuses, which continue into adulthood. A vast majority of
these studies suggest that during chronic nutritional restriction the mechanisms that regulate the
metabolism of nutrients develop a marked tendency towards their accumulation, prioritizing anabolic
processes over catabolic ones, that is, tissues sensitive to action of insulin show different adaptations
that increase the action of it. Among others, there has been an increase in the translocation of GLUT-4
(glucose transporter type 4) in skeletal muscle [77,78] and an increase in glucose uptake and lipogenesis
in adipose tissue [79–81]. However, animals subjected to nutritional restriction show a decrease in
circulating insulin levels, possibly with the aim of compensating for the increased sensitivity to the
hormone and thus allowing the correct supply of glucose to the brain.
Despite the fact that in recent years there have been important advances in this field, the intrinsic
causes that motivate the appearance of diseases in adults, in relation to their previous nutritional status,
have not yet been fully clarified. However, in a scenario of early nutritional restriction and subsequent
feedback with a fat diet, the accumulation of nutrients in the form of fat appears to be predominant
over its use for energy, which is known as accelerated growth of adipose tissue or catch-up fat [82,83].
This energy saving mechanism aims to ensure a nutritional reserve for subsequent periods of food
shortage. Therefore, in developing societies, where less balanced and more abundant and energetic
diets are consumed, this saving feature seems to be decisive in the exponential growth of obesity and
type 2 diabetes [84,85].
3.4. Excessive Calories Consumption in the Maternal Diet and Influence on the Development
The focus on programming research has evolved from studies of malnutrition to those of excessive
consumption of maternal calories and obesity, a major global public health problem that affects
more than 50% of women in many countries. Maternal obesity (either before pregnancy or during
pregnancy), could induce a critical situation known as “excessive fetal nutrition” [14], that increases
the risk of obesity and complications in the offspring. There are plenty of studies in animals and
observational studies in humans, which support this hypothesis [14,86–88]. Consistent associations
have been identified [87] between increased adiposity in the offspring with maternal body mass
index before pregnancy, increased gestational weight, gestational diabetes, and excessive birth weight.
The hypothesis of excessive fetal nutrition is supported by the neonates of mothers who lose weight
after bariatric surgery have a lower risk of obesity compared to babies of the same mother born before
surgery [89].
Prevention strategies are of vital importance to avoid the persistence of obesity during growth
and maturation and in adulthood, especially for the prevention of comorbidities associated with
the medium and long term [90,91]. Evidence shows the effects of programming antenatal care on
subsequent obesity and the appearance of chronic diseases related with nutrition [92]. Weight gain
in pregnant women that influences in the fetus metabolism, as well as low and high birth weight,
followed by early and excessive weight gain during the first two years of life, are associated with a
significant increase in risk of subsequent obesity [93,94]. Even though an overweight or obese child or
adolescent will not always be an obese adult, this condition is associated with high risk of persistence in
adulthood: obesity a the two-year-old increases the risk 1.3 times, while if maintained until 15–17 years,
the risk is 17 times higher, compared to their eutrophic pairs [95].
Maternal nutritional status before and during pregnancy has a key role on fetal growth, increasing the
possibility of developing obesity in later life, due to the programming effect during this stage,
as demonstrated by epidemiological and experimental studies [96]. Changes in fetal gene expression,
which are induced by maternal nutrition, are called epigenetic nutritional changes and appear to be
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associated with DNA methylation. Prolonged exposures to diets that influence chromatin remodeling
and DNA methylation can induce permanent epigenetic changes in the genome. Decreased methylation
may be related to slow intrauterine growth. Maternal nutrient restrictions [97] and excessive caloric
intake [98] are related to the nutritional epigenetic programming of metabolic disorders [97].
It has been shown that maternal dietary intake and phenotypic adaptations in the offspring have a
U-shaped relationship, as demonstrated by observational studies in humans, indicating that alterations
that affect normal growth patterns, increasing the risk of obesity, type II diabetes mellitus and metabolic
disorders in the offspring, due to both deprivation or nutrients excess in utero [99]. In this sense,
higher degrees of maternal obesity increase the risk of developing perinatal complications, such as
preeclampsia, macrosomia, and delivery by cesarean section [100]. As is known, obese women have
a higher predisposition to lipotoxicity, metabolic dysregulation, oxidative stress and inflammation
that those with normal body mass index, which can be exacerbated by fat accumulation during
pregnancy [101,102].
As previously mentioned, excessive weight of the pregnant mother affects her health and that of
the offspring. Overweight and maternal obesity are highly correlated with neonatal fat mass in the
first hours of life [103], and overweight in the adult stage [104]. On the other hand, obese women have
between 3–6 times the risk of having macrosomic newborns, being a determining factor for overweight
and obesity during childhood and adolescence [105]. On the other hand, adequate birth weight has
been associated with a higher lean mass and lower fat mass compared to low birth weight infants [106].
High prenatal intake of energy, protein and micronutrient deficiency has been linked to an increased
risk of obesity in the adult stage of the offspring and obese women consume highly energetic diets but
poor in essential micronutrients [107].
Taking into account the evidence in the scientific literature that shows the impact of maternal
nutrition on the risk of chronic diseases in the adult life of the offspring, several researchers have
undertaken studies to determine possible strategies that can reverse these effects from early stages of
life. The objective of these studies is therefore to prevent obesity and related diseases in the future
adult life of individuals characterized by poor metabolic programming. In order to reverse the effects
of programming, these strategies must be carried out in critical stages of fetal and/or neonatal life,
that is, in periods that correspond to the development and/or maturation of different systems and are
thus liable to exert the effects of each strategy and reverse the programming.
Due to its relevance as a neurotrophic factor and regulator of energy homeostasis, leptin supplementation
in postnatal life is an important reversal strategy, which has many evidences in favor of its effectiveness.
During the second week of life, a surge of leptin occurs that coincides with the development of
hypothalamic circuits. The origin of this leptin surge is still a matter of controversy, although it is
suggested that neonatal leptin comes from breast milk, through lactation, since in that period the
adipose tissue is still immature. This fact has been supported by the rapid decrease in leptin levels in
neonates separated from the mother at birth, as well as by the increased risk of obesity in children fed
a lactating formula instead of breastfeeding [108]. Therefore, a leptin supplementation in this period,
may have the ability to reverse some of the neuroanatomical effects and other characteristics of the obese
phenotype associated with the absence of the leptin surge. Specifically, intraperitoneal injections of
leptin (10 mg/kg) between day 4 and 12 of life in leptin-deficient mice (ob/ob mice), have shown a reversal
in the altered development of hypothalamic circuits related to hunger [109]. Similarly, daily injections
of subcutaneous leptin (2.5 µg/g/day) during the first 13 days of life in offspring of rats subjected
to a 30% caloric restriction [110] during pregnancy, have showed a normalization in caloric intake,
locomotor activity, body weight, fat mass and in glucose, insulin and leptin levels in adult life.
The metabolic dysfunctions caused by the lack of leptin signaling during early life involve
changes that affect energy homeostasis, reproduction and brain development. Although the complete
absence of leptin signaling is rarely found in humans, both undernutrition and overnutrition are able
to produce significant changes in leptin concentrations, leptin sensitivity or in the development of
neurocircuits that regulate energy homeostasis [111–113]. Therefore, intrauterine or early postnatal
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changes in energy balance have been consistently linked with obesity and other metabolic diseases in
adulthood [114–116].
Konieczna et al. [109] reported the effectiveness of the administration of oral doses of leptin through
lactation in terms of reversing poor programming. This treatment was administered to offspring
of rats descended from mothers subjected to a 20% caloric restriction during the first 12 days of
pregnancy, associated with alterations in the hypothalamic circuits as a consequence of said conditions.
Specifically, supplementation consisted of administering 1 ng of leptin on day 1 of life to the offspring
and gradually increasing the dose to reach 43.8 ng on day 20 of life. The results of this study showed
that this oral administration of leptin during lactation led to the reversal of neuroanatomical disorders,
produced as a consequence of maternal caloric restriction.
4. Exercise and Metabolic Programming
There is evidence that maternal malnutrition in rats results in decreased physical activity, leading to
a sedentary life in the offspring. Specifically, a study carried out under conditions of maternal protein
restriction during pregnancy showed a significant decrease in voluntary locomotive activity in their
offspring [18,19]. Thus, it has been suggested that moderate exercise activity is necessary to prevent
possible metabolic disturbances in the offspring and also may have a positive correlation with offspring’s
neurodevelopment and language (in children from 18 to 60 months) [20]. It also has been reported that
a combination of aerobic-resistance exercises of moderate-to-vigorous intensity in pregnant women
from the 17th week until delivery (3 days/week, 60 min/session) is a complementary-alternative tool to
modulate the immune status, avoiding future immunometabolic impairments and prevent pregnancy
complications [117].
Physical exercise causes physiological changes that depend on the type, intensity and duration
of the effort, as well as the physical training, age, gender and nutritional status of the individual.
In pregnant women, it often happens that they decrease their physical activity and restrict physical
exercise. Recently, new knowledge about the risk/benefit ratio of exercise during pregnancy has emerged,
making consensus and recommendations essential to guide public health policies [118]. Training during
pregnancy is safe and positive as reported by several studies [119–121]. Exercise improves overall health
status in pregnant women and they feel better and experience fewer pregnancy-related symptoms [121],
being the cardiovascular responses to exercise in pregnant women similar to those observed in
non-pregnant women [120].
Furthermore, it is known that regular physical exercise of moderate intensity, and early onset
(first 20 weeks of gestation), increases placental blood perfusion and functional capacity. In this
way, exercise can prevent placental abnormalities, one of the underlying causes of preeclampsia
leading to decreased cell perfusion and placental hypoxia. In addition, the resulting oxidative stress
causes endothelial dysfunction can trigger high blood pressure and preeclampsia, but also induce
the development of gestational diabetes [122]. In this sense, as physical exercise renews placental
perfusion, improves the supply of nutrients necessary for fetal development, and substantially reduces
the risk of developing pre-eclampsia [123].
All of these cardiovascular changes contribute to overall improved health post-partum,
decreasing complications during labor and delivery, time for maternal recovery and lifelong adverse
conditions [124]. Therefore, there are numerous maternal and pregnancy benefits related exercise
while pregnant that can have a clear beneficial impact on adulthood health.
5. Sleep and Metabolic Programming
Sleep duration and quality has an impact in dietary patterns. This new area of research in nutritional
sciences studying the impact of the timing of eating on health outcomes is called chrono-nutrition,
and combines elements from nutritional research with chrono-biology which has a direct impact on
health outcomes [22]. Physiological changes that occur during pregnancy are also associated with
changes in sleep architecture. Total sleep time increases slightly in the first trimester of pregnancy
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compared to the non-pregnant woman and increases in a more pronounced way during the third
trimester. Sleep disturbances are present during all gestation, but during the third trimester a greater
impact on the quality and quantity of sleep is observed [125] in this period, the total sleep time
increases approximately half an hour and is accompanied by a reduction in the quality of sleep [126].
Alterations of the circadian rythm can lead to various adverse reproductive outcomes. In addition
to the clock, lipid metabolism may also play a key role in fetal development. In the study of
Kovac et al. [127], they found a modest interaction between a single nucleotide polymorphism in
PER3 and triglycerides on the association with preterm birth. Sleep disturbances during pregnancy
might be detrimental to both mother and offspring by promoting increased risk at the behavioural,
electrophysiological, metabolic and epigenetic levels and are associated with some hormonal changes,
including: increased progesterone levels (causing fatigue and daytime sleepiness), increased estrogen
levels (which selectively decrease REM sleep activation in the preoptic ventrolateral area), alterations in
cortisol secretion (which decreases REM sleep and increases slow wave sleep), alterations in prolactin
levels (which exacerbates slow wave sleep), alterations in growth hormone levels (associated with
the initiation and maintenance of slow wave sleep) and these changes play an important role in the
growth and development of the fetus [21,128]. Although these changes obey a normal physiological
process in pregnant women, they can generate complications, especially when obesity occurs, since the
prevalence of sleep apnea is higher. Furthermore, in several studies it has been described that women
with pre-eclampsia, a condition associated with maternal obesity, more frequently present respiratory
disturbances, nocturnal hypoxia events and obstructive sleep apnea [129,130]. In addition, sleep is one
of the primary activities of the brain during early development and plays an important role in healthy
cognitive and psychosocial development during the childhood [131].
Serum melatonin levels in pregnant women have a diurnal rhythmicity with significant increases
towards the end of pregnancy [132]. Melatonin is transferred from the maternal blood into the fetal
circulation with high efficiency, in spite of the fetus can produce its own melatonin with circadian
rhythmicity [133,134]. The placental dysfunction, which is suggested as a consequence of the decrease
in melatonin levels or of the alterations in its secretion rhythm, raises the possibility that the disruption
of light-dark cycles during pregnancy has long-term metabolic consequences, including an increase
in adiposity, hyperleptinemia, hyperinsulinemia and glucose intolerance [135,136]. Although the
mechanisms through which these alterations are generated have not been fully elucidated, it has been
suggested that melatonin may play an important role in the establishment of metabolic alterations in
adulthood [136]. Maternal melatonin can affect the functions of the placenta and the fetal organism [137].
Melatonin has been reported to counteract the generation of free radicals by avoiding the oxidative
stress that characterizes the early stages of placental abnormalities. In this sense, women with
preeclampsia who show low levels of melatonin have deficiencies in the passage of nutrients and
oxygen supply to the fetus, which promotes complications of pregnancy, premature delivery and low
birth weight [137]. On the other hand, depending on its secretion rhythm, the melatonin produced
by the maternal organism is easily transported through the placenta and reaches the fetal circulation.
It is essential to regulate some functions during development: maturation of the nervous system,
regulation of neonatal temperature, determination of the circadian rhythms of other tissues such as the
liver, synchronization of the circadian cycles of the fetus [137], mediation in the expression of the leptin
gene in adipocytes through its interaction with specific receptors [138], which promotes the control of
food intake and favors the regulation of body weight [139,140] as well as the adequate function of the
pancreas and glucose metabolism [141]. It is interesting, therefore, to highlight the relevance of sleep
problems during pregnancy, which influence adequate growth and fetal development, early preventing
the development of obesity and metabolic diseases. Finally, melatonin supplementation in pregnancy
and lactation may serve as a reprogramming strategy against the development of cardiovascular and
neurological diseases [142].
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6. Conclusions
Nutritional, endocrine, metabolic and lifestyle factors in the mother during pregnancy profoundly
influence the growth and development of the fetus and progeny, altering tissue function, facts that
can affect the susceptibility to several disorders latter in life. Nutrition in early life establishes
profound physiological and metabolic changes that determine the risk of diseases that occur with
aging. Malnutrition of the fetus causes intrauterine growth retardation, inducing a low birth weight
and has detrimental effects on the development and subsequent functioning of the organs, which affect
the renal, cardiovascular, respiratory, and endocrine systems. On the other hand, excessive maternal
nutrition causes macrosomia, with greater adiposity and a trend towards childhood obesity, type 2
diabetes mellitus and cardiovascular diseases. Intrauterine hyperglycemia is associated with an
increased risk of obesity, metabolic disease in offspring. Moderate exercise activity is necessary to
prevent possible metabolic disturbances in the offspring and also physical activity practice may have
a positive association with language offspring’s neurodevelopment and is a complementary tool to
modulate the immune status of pregnant women and their newborns. Finally, sleep problems during
pregnancy influence adequate growth and fetal development, early preventing the development of
obesity and metabolic diseases. However, this narrative review has some limitations because describes
and appraises published articles available, but may include potential selection and evaluation biases.
This is in contrast to systemic reviews and meta-analyses, whose queries, criteria, and article selection
processes are well-defined. Despite these limitations, our review may provide novel insights into
early development factors and also provides strategies for prevention and management of the risk of
metabolic disorders in adulthood and potential impacts on the health of the next generation.
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